Shenzhen Weiguang Biological Products Co., Ltd. announced a private placement of not more than 34,340,000 shares for gross proceeds of not more than CNY 1,150,000,000 on March 9, 2022. The issue price is not less than 80% of the average price in the 20 trading days before the pricing reference date. The transaction will include participation from not more than 35 investors.

All securities issued in the transaction have a hold period of 6 months. The transaction has been approved in the 2nd meeting of it's 3rd directorate and by 65.25% shareholder Shenzhen Guangming District State-owned Assets Supervision and Administration Bureau, and is subject to the approvals of the it's shareholders and the China Securities Regulatory Commission.